Market Overview

Earnings Scheduled For March 19, 2014

Share:
Earnings Scheduled For March 19, 2014
Related FDX
Loop Questions Why FedEx Shares 'Always Seem So Cheap'
Benzinga's Top Upgrades, Downgrades For April 7, 2017
Related ESLT
Global Defense Firms Will Build $82 Billion In Drones In A Decade
11 Stocks Moving In Monday's Pre-Market Session

FedEx (NYSE: FDX) is projected to report its Q3 earnings at $1.46 per share on revenue of $11.43 billion.

Elbit Systems (NASDAQ: ESLT) is estimated to report its Q4 earnings at $1.41 per share on revenue of $839.97 million.

General Mills (NYSE: GIS) is projected to report its Q3 earnings at $0.64 per share on revenue of $4.41 billion.

Jabil Circuit (NYSE: JBL) is expected to post its Q2 earnings at $0.11 per share on revenue of $3.61 billion.

KB Home (NYSE: KBH) is estimated to report its Q1 earnings at $0.08 per share on revenue of $435.30 million.

Guess' (NYSE: GES) is expected to post its Q4 earnings at $0.79 per share on revenue of $762.94 million.

Vera Bradley (NASDAQ: VRA) is projected to report its Q4 earnings at $0.46 per share on revenue of $146.86 million.

Bacterin International Holdings (NYSE: BONE) is estimated to post a Q4 loss at $0.07 per share on revenue of $8.00 million.

CLARCOR (NYSE: CLC) is expected to post its Q1 earnings at $0.41 per share on revenue of $317.45 million.

Cintas (NASDAQ: CTAS) is projected to post its Q3 earnings at $0.69 per share on revenue of $1.13 billion.

Franco-Nevada (NYSE: FNV) is estimated to post its Q4 earnings at $0.22 per share on revenue of $96.32 million.

Tilly's (NYSE: TLYS) is expected to post its Q4 earnings at $0.18 per share on revenue of $139.75 million.

Herman Miller (NASDAQ: MLHR) is projected to post its Q3 earnings at $0.34 per share on revenue of $457.60 million.

Actuant (NYSE: ATU) is expected to report its Q2 earnings at $0.32 per share on revenue of $333.74 million.

The ExOne Company (NASDAQ: XONE) is estimated to post its Q4 earnings at $0.01 per share on revenue of $12.13 million.

Sinovac Biotech (NASDAQ: SVA) is projected to post a Q4 loss at $0.01 per share on revenue of $20.35 million.

Posted-In: Earnings scheduleEarnings News Pre-Market Outlook Markets

 

Related Articles (ATU + BONE)

View Comments and Join the Discussion!